Navigation Links
-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
Date:3/6/2008

SEATTLE, March 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) will release its fourth quarter financial results on Thursday, March 13, 2008. Company management will host a conference call at 8:00 a.m. PT; 11:00 a.m. ET to review fiscal year 2007 financial results and provide 2008 financial guidance. Access to the discussion may be obtained as follows:

Time: 11:00 AM ET /8:00 AM PT

Date: March 13, 2008

Dial-in: 1-877-548-7901 (domestic) or +1-719-325-4844 (international)

Webcast: http://www.dendreon.com (homepage and investor relations

section)

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-888-203-1112 or +1-719-457-0820 for international callers; the conference ID number is 5074038. The replay will be available from 7:30 pm ET on Thursday, March 13 until 11:59 pm ET on Saturday, March 15. In addition the webcast will be archived for on-demand listening for 30 days at http://www.dendreon.com.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has headquarters in Seattle and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Alsius Corporation to Host Fourth Quarter and Year-End 2007 Financial Results Conference Call/Webcast on March 13, 2008
2. VWR Funding, Inc. to Hold Fourth Quarter and Year-End 2007 Financial Results Conference Call
3. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
4. First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference
5. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
6. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
7. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
8. SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
10. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
11. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... by its Chairman and CEO, Jim Joyce . ... Security Conference last Saturday, Bill Gates warned ... more people than nuclear weapons. Mr. Gates expressed his ... intelligence agencies, that scientific terrorists have access to the ...
(Date:2/24/2017)... ... 2017 , ... FireflySci, Inc is an explosive small business that continues to ... of bringing their powerful cuvette and spectrophotometer calibration to the spectroscopy world. ... going on as they add yet another mark on the global map. , With ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... leading digital health company, and Digital Noema ... and remote patient monitoring, announce they are partnering ... DN Telehealth maximizes collaboration compatibility for ... consultations beyond a physical clinical setting to include ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
Breaking Biology Technology:
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
(Date:1/24/2017)... Jan. 24, 2017  It sounds simple and ... that monitors vital signs and alerts parents on ... oxygen saturation level drops. But pediatric experts argue ... parents, with no evidence of medical benefits, especially ... marketed aggressively to parents of healthy babies, promising ...
Breaking Biology News(10 mins):